Natural Capsules Q4 Results
- BSE: 524654
- NSE: NATCAPSUQ
- ISIN: INE936B01015
- Sector: Biotechnology & Drugs
BSE
141.30
-4.10 (-2.82%)
-4.10 (-2.82%)Volume138.00
Updated: Fri 17 Jul, 2026 | 15:23:01
NSE
143.21
1.10 (0.77%)
1.10 (0.77%)Volume1.02 K
Updated: Fri 17 Jul, 2026 | 15:25:40
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹58.45 Cr.(29.98%)
- Operating Profit₹-2.95 Cr.(NA%)
- Profit After Tax₹-3.45 Cr.(NA%)
- Operating Margin-5.05%(NA%)
Note: Comparison is on YoY basis
Quarterly - Natural Capsules Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 61.40 | 44.43 | 38.20% | 38.30 | 43.65% |
| Depreciation/ Amortization | 4.28 | 4.36 | -1.84% | 2.21 | 98.56% |
| Operating Income | -2.95 | -6.69 | -55.87% | 1.92 | 0.00% |
| Net Income | -3.45 | -7.12 | -51.59% | 0.96 | 0.00% |
| Other Operating Expenses Total | 16.16 | 15.37 | 5.12% | 11.84 | 14.84% |
| Net Income Before Taxes | -5.08 | -9.08 | -44.12% | 1.43 | 0.00% |
| Total Revenue | 58.45 | 37.75 | 54.86% | 40.22 | 29.98% |
| Selling/ General/ Admin Expenses Total | 5.48 | 5.73 | -4.29% | 3.52 | 47.63% |
| Diluted Normalized EPS | -4.82 | -6.88 | -29.94% | 1.03 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.